Glaucoma: now and beyond

H Jayaram, M Kolko, DS Friedman, G Gazzard - The Lancet, 2023 - thelancet.com
The glaucomas are a group of conditions leading to irreversible sight loss and characterised
by progressive loss of retinal ganglion cells. Although not always elevated, intraocular …

Glaucoma in adults—screening, diagnosis, and management: a review

JD Stein, AP Khawaja, JS Weizer - Jama, 2021 - jamanetwork.com
Importance Glaucoma is the most common cause of irreversible blindness worldwide. Many
patients with glaucoma are asymptomatic early in the disease course. Primary care …

The diagnosis and treatment of glaucoma

AK Schuster, C Erb, EM Hoffmann… - Deutsches …, 2020 - pmc.ncbi.nlm.nih.gov
Background Glaucoma is a group of chronically progressive disorders of the optic nerve. In
this article, we present the epidemiology of and risk factors for glaucoma, as well as the …

Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial

M He, Y Jiang, S Huang, DS Chang, B Munoz, T Aung… - The Lancet, 2019 - thelancet.com
Background Primary angle-closure glaucoma affects 20 million people worldwide. People
classified as primary angle closure suspects have a higher but poorly quantified risk of …

[HTML][HTML] Primary angle closure glaucoma: what we know and what we don't know

X Sun, Y Dai, Y Chen, DY Yu, SJ Cringle… - Progress in retinal and …, 2017 - Elsevier
Primary angle-closure glaucoma (PACG) is a common cause of blindness. Angle closure is
a fundamental pathologic process in PAGC. With the development of imaging devices for the …

The surgical management of glaucoma: A review

R Lim - Clinical & Experimental Ophthalmology, 2022 - Wiley Online Library
After a long period of little change, glaucoma surgery has experienced a dramatic rise in the
number of possible procedures in the last two decades. Glaucoma filtering surgeries with …

Current management of glaucoma

J Lusthaus, I Goldberg - Medical Journal of Australia, 2019 - Wiley Online Library
Glaucoma is an irreversible progressive optic neuropathy, for which the major proven
treatment is to lower the intraocular pressure (IOP). Five groups of IOP‐lowering eye drops …

[HTML][HTML] Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease …

Y Sun, A Chen, M Zou, Y Zhang, L **, Y Li, D Zheng… - BMJ open, 2022 - bmjopen.bmj.com
Objective To estimate global prevalence of blindness and vision loss caused by glaucoma,
and to evaluate the impact of socioeconomic factors on it. Design A population-based …

Cataracts

MV Cicinelli, JC Buchan, M Nicholson, V Varadaraj… - The Lancet, 2023 - thelancet.com
Summary 94 million people are blind or visually impaired globally, and cataract is the most
common cause of blindness worldwide. However, most cases of blindness are avoidable …

The Japan Glaucoma Society guidelines for glaucoma 5th edition

Y Kiuchi, T Inoue, N Shoji, M Nakamura… - Japanese Journal of …, 2023 - Springer
We are pleased to bring you the 5th edition of the Glaucoma Clinical Practice Guidelines.
Clinical practice guidelines are based on evidence (scientific grounds). It is a document that …